NCT03096041

Phase 3 Study Randomized Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors

Phase 3 Study Randomized Against Placebo, Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors in Adjuvant Treatment of Breast Cancer (TRIPLE-A)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 197 (actual)
• Sponsor: Centre Francois Baclesse · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Auriculotherapy is a complementary medicine, with few side effects, without contraindication, inexpensive and not very restrictive.Its efficacy has been found in several tests especially for the treatment of intraoperative pain. It remains more controversial in other indications. Evaluation of the value of auriculotherapy is often difficult because of the methodological limitations of the trials conducted. In the daily practice, the auriculotherapy is proposed to improve the articular pains of patients treated by AA. This Phase III study aims at validate this approach.

Conditions

• Musculoskeletal Pain
• Breast Cancer

Interventions

Type	Name	Description
DEVICE	Auriculotherapy for analgesic use	The ASP will be applied to specific pain points
DEVICE	Placebo auriculotherapy	The ASP will be applied to placebo points (not specific to pain)

Timeline

• Start date: 2017-07-05
• Primary completion: 2025-07-07
• Completion: 2025-07-07
• First posted: 2017-03-30
• Last updated: 2025-09-12

Locations

7 sites across 1 country: France